{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:52:37Z","timestamp":1794279157552,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.healun.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T19:22:35Z","timestamp":1721503355000},"page":"1948-1959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-2434","authenticated-orcid":false,"given":"Entela","family":"Bollano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne K.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-1924","authenticated-orcid":false,"given":"Hans","family":"Eiskjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-2771","authenticated-orcid":false,"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4316-805X","authenticated-orcid":false,"given":"Kaspar","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea A.S.","family":"Halden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Karason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-6154","authenticated-orcid":false,"given":"Sven-Erik","family":"Bartfay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7440-2366","authenticated-orcid":false,"given":"Niklas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.07.002_bib1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report - 2021; focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2016.12.186","article-title":"Continuous improvement in outcome after heart transplantation - long-term follow-up after three decades of experience","volume":"231","author":"Dellgren","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2024.07.002_bib3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report\u20132014; focus theme: retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jtcvs.2017.11.087","article-title":"Renal function and outcome after heart transplantation","volume":"155","author":"Kolsrud","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.07.002_bib5","unstructured":"C S. Cancer in organ transplant recipients. 2021."},{"key":"10.1016\/j.healun.2024.07.002_bib6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.07.002_bib9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","article-title":"The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report\u20132012","volume":"31","author":"Stehlik","year":"2012","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib10","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1517\/14656566.7.17.2369","article-title":"Treatment of allograft vasculopathy in heart transplantation","volume":"7","author":"Segovia","year":"2006","journal-title":"Expert Opin Pharm"},{"key":"10.1016\/j.healun.2024.07.002_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-200565050-00004","article-title":"Combating chronic renal allograft dysfunction: optimal immunosuppressive regimens","volume":"65","author":"Merville","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.healun.2024.07.002_bib12","article-title":"Everolimus in heart transplantation: an update","volume":"2013","author":"Hirt","year":"2013","journal-title":"J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.trre.2013.03.002","article-title":"Everolimus immunosuppression in de novo heart transplant recipients: what does the evidence tell us now?","volume":"27","author":"Zuckermann","year":"2013","journal-title":"Transpl Rev (Orlando)"},{"key":"10.1016\/j.healun.2024.07.002_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo heart transplant recipients","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2024.07.002_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1432-2277.2008.00771.x","article-title":"Calcineurin-inhibitor minimization protocols in heart transplantation","volume":"22","author":"Zuckermann","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2024.07.002_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025507","article-title":"Characteristics, predictors, and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database","volume":"11","author":"Kampaktsis","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.07.002_bib19","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib20","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.07.002_bib22","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.healun.2022.05.012","article-title":"International society for heart and lung transplantation statement on transplant ethics","volume":"41","author":"Holm","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2024.07.002_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.healun.2024.07.002_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2018.03.111","article-title":"Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis","volume":"265","author":"Jennings","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2024.07.002_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.healun.2019.08.003","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match","volume":"38","author":"Hayes","year":"2019","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10741-020-09967-3","article-title":"Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimens","volume":"27","author":"Ueyama","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2024.07.002_bib29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.healun.2007.03.010","article-title":"Is there a role for proliferation signal\/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology","volume":"26","author":"Valantine","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib30","article-title":"Everolimus and malignancy after solid organ transplantation: a clinical update","volume":"2016","author":"Holdaas","year":"2016","journal-title":"J Transpl"},{"key":"10.1016\/j.healun.2024.07.002_bib31","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2024.07.002_bib32","first-page":"93","article-title":"Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy","volume":"9","author":"Rivinius","year":"2015","journal-title":"Drug Des Devel Ther"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824017327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824017327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T07:22:13Z","timestamp":1731568933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824017327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1053249824017327"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.07.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}